Fig. 3From: Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyondMechanism of small molecule therapeutics in multiple myeloma therapy. FDA-approved medications are shown in red text and investigational therapies discussed in review text and Table 4 are shown in blue textBack to article page